The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Alsharifi, M.
Right arrow Articles by Müllbacher, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alsharifi, M.
Right arrow Articles by Müllbacher, A.
The Journal of Immunology, 2005, 175: 4635-4640.
Copyright © 2005 by The American Association of Immunologists

Type I Interferons Trigger Systemic, Partial Lymphocyte Activation in Response to Viral Infection

Mohammed Alsharifi, Mario Lobigs, Matthias Regner, Eva Lee, Aulikki Koskinen and Arno Müllbacher1

Division of Immunology and Genetics, The John Curtin School of Medical Research, Australian National University, Canberra, Australia

The vast majority of both T and B cells in mice were found to up-regulate cell surface expression of the early activation markers CD69 and CD86, but not CD25, within 24 h of infection with Semliki Forest virus. Kinetics and magnitude of activation marker expression was dependent on live virus, dose, and correlated with strain virulence. Activation marker expression declined to baseline levels over the next 96 h. This very early "activation" of such a high percentage of lymphocytes required the presence of type I IFN receptor genes, was inducible with poly(I:C), and correlated with IFN-I levels in serum. We conclude that virus-induced IFN-I release systemically affects most of the hosts T and B cells by triggering them rapidly and independently of Ag-reactivity into a semiactivated state.




This article has been cited by other articles:


Home page
J. Immunol.Home page
S. L. Day, I. A. Ramshaw, A. J. Ramsay, and C. Ranasinghe
Differential Effects of the Type I Interferons {alpha}4, {beta}, and {epsilon} on Antiviral Activity and Vaccine Efficacy
J. Immunol., June 1, 2008; 180(11): 7158 - 7166.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Yoon, K. L. Legge, S.-s. J. Sung, and T. J. Braciale
Sequential Activation of CD8+ T Cells in the Draining Lymph Nodes in Response to Pulmonary Virus Infection
J. Immunol., July 1, 2007; 179(1): 391 - 399.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. E. Kohlmeier, S. C. Miller, and D. L. Woodland
Cutting Edge: Antigen Is Not Required for the Activation and Maintenance of Virus-Specific Memory CD8+ T Cells in the Lung Airways
J. Immunol., April 15, 2007; 178(8): 4721 - 4725.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Alsharifi, M. Regner, R. Blanden, M. Lobigs, E. Lee, A. Koskinen, and A. Mullbacher
Exhaustion of Type I Interferon Response following an Acute Viral Infection.
J. Immunol., September 1, 2006; 177(5): 3235 - 3241.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. S. Hidmark, E. K. L. Nordstrom, P. Dosenovic, M. N. E. Forsell, P. Liljestrom, and G. B. Karlsson Hedestam
Humoral Responses against Coimmunized Protein Antigen but Not against Alphavirus-Encoded Antigens Require Alpha/Beta Interferon Signaling
J. Virol., July 15, 2006; 80(14): 7100 - 7110.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.